MEMANTINE IN THE ALLEVIATION OF SYMPTOMS OF CHRONIC PELVIC PAIN SYNDROME: A RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL

In: Journal of Urology · 2009 · vol. 181(4S) , pp. 123 · doi:10.1016/s0022-5347(09)60353-0 · W2030510501
article OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View at publisher
AI-generated summary by qwen3.7-flash, 2026-08-24

This randomized, double-blind, placebo-controlled trial investigated the efficacy of memantine in alleviating symptoms of chronic pelvic pain syndrome.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

You have accessJournal of Urology1 Apr 2009MEMANTINE IN THE ALLEVIATION OF SYMPTOMS OF CHRONIC PELVIC PAIN SYNDROME: A RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL Jordan D Dimitrakov, Jean Chitalov, and Ivan Dechev Jordan D DimitrakovJordan D Dimitrakov , Jean ChitalovJean Chitalov , and Ivan DechevIvan Dechev View All Author Informationhttps://doi.org/10.1016/S0022-5347(09)60353-0AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "MEMANTINE IN THE ALLEVIATION OF SYMPTOMS OF CHRONIC PELVIC PAIN SYNDROME: A RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL." The Journal of Urology, 181(4S), p. 123 © 2009 by American Urological AssociationFiguresReferencesRelatedDetails Volume 181Issue 4SApril 2009Page: 123 Advertisement Copyright & Permissions© 2009 by American Urological AssociationMetricsAuthor Information Jordan D Dimitrakov More articles by this author Jean Chitalov More articles by this author Ivan Dechev More articles by this author Expand All Advertisement PDF downloadLoading ...

My notes (saved in your browser only)

Condition tags

chronic_pelvic_pain

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-09-07T06:27:18.705824+00:00
License: CC0 · commercial use OK